Diabetes: Certain J&J insulin pumps destined to fail over software issue

Tue, 01/22/2013 - 3:33pm
Mass Device

Johnson & Johnson subsidiary Animus Corp. warns that certain of its Animas insulin pumps will become defunct at the stroke of midnight on December 31, 2015.

Example Animus insulin pump

Johnson & Johnson (NYSE:JNJ) subsidiary Animas Corp. warned European regulators that certain of the company's ambulatory insulin pumps contain a software flaw that will render the devices defunct on the stroke of midnight on December 31, 2015.

The Animas IR1200, IR1250 and 2020 models, which the company no longer distributes in the U.K., will stop delivering insulin at the start of 2016 and will generate a "call service alarm," according to the U.K.'s Medicines & Healthcare products Regulatory Agency.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.